Arrowstreet Capital, Limited Partnership Aurinia Pharmaceuticals Inc. Transaction History
Arrowstreet Capital, Limited Partnership
- $148 Billion
- Q3 2025
A detailed history of Arrowstreet Capital, Limited Partnership transactions in Aurinia Pharmaceuticals Inc. stock. As of the latest transaction made, Arrowstreet Capital, Limited Partnership holds 3,374,021 shares of AUPH stock, worth $51.8 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
3,374,021
Previous 1,076,118
213.54%
Holding current value
$51.8 Million
Previous $9.11 Million
309.06%
% of portfolio
0.03%
Previous 0.01%
Shares
4 transactions
Others Institutions Holding AUPH
# of Institutions
269Shares Held
69.3MCall Options Held
984KPut Options Held
574K-
Tang Capital Management LLC San Diego, CA11.3MShares$174 Million5.69% of portfolio
-
Black Rock Inc. New York, NY9.27MShares$142 Million0.0% of portfolio
-
Nea Management Company, LLC Timonium, MD3.97MShares$60.9 Million2.74% of portfolio
-
State Street Corp Boston, MA2.69MShares$41.3 Million0.0% of portfolio
-
Morgan Stanley New York, NY1.95MShares$29.9 Million0.0% of portfolio
About Aurinia Pharmaceuticals Inc.
- Ticker AUPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,892,000
- Market Cap $2.18B
- Description
- Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...